Outcomes of nivolumab (NIVO)-treated patients (pts) with advanced non-small cell lung cancer (aNSCLC) in United States community oncology practice.
2019
119Background: The phase 3 Checkmate 017 and 057 trials demonstrated improved survival of NIVO vs. chemotherapy in pts who progressed on or after platinum-based chemotherapy for aNSCLC, regardless ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI